Location History:
- Newbury Park, CA (US) (2019 - 2022)
- Thousand Oaks, CA (US) (2007 - 2023)
Company Filing History:
Years Active: 2007-2023
Title: Ying Chen: Innovator with a String of Patents in Thousand Oaks
Introduction:
Meet Ying Chen, a talented innovator hailing from Thousand Oaks, California. With an impressive nine patents under his name, Chen has made significant contributions to the field of pharmaceuticals and drug formulations. In this article, we will delve into Chen's latest patents, highlight his career achievements, and shine a light on his notable collaborations.
Latest Patents:
Chen's most recent patents showcase his expertise in the pharmaceutical industry. One remarkable patent is titled "Solid forms of Cerdulatinib." This invention involves the preparation and characterization of solid forms, salts, or co-crystals of cerdulatinib. Additionally, Chen has developed processes for manufacturing these forms and methods of utilizing them. This patent demonstrates Chen's commitment to advancing drug development and formulation processes.
Another noteworthy patent by Chen is named "Method for preparing AMG 416 (etelcalcetide)." This invention involves a method for preparing AMG 416, a vital pharmaceutical compound. This patent highlights Chen's contribution to the development of innovative and efficient methods for manufacturing pharmaceuticals.
Career Highlights:
Ying Chen's career has been marked by his association with renowned pharmaceutical companies. He has contributed significantly to the advancements made by Amgen Inc and Alexion Pharmaceuticals, Inc. Amgen Inc, an industry giant, has employed Chen's expertise and benefited from his innovative thinking. Similarly, Chen has made valuable contributions during his tenure at Alexion Pharmaceuticals, Inc., further solidifying his reputation as a top innovator in the field.
Collaborations:
Innovation often thrives when great minds come together, and Chen has been fortunate to collaborate with exceptional individuals. Among his notable coworkers are Anjali Pandey and Richard Crockett. These collaborations have likely resulted in groundbreaking advancements, ensuring that his patents and inventions are well-rounded and comprehensive.
Conclusion:
Ying Chen is an incredibly accomplished innovator, particularly in the field of pharmaceuticals and drug formulation. With his nine patents, including the groundbreaking inventions related to cerdulatinib and AMG 416, Chen has established himself as a prominent figure in the industry. His collaborations with colleagues like Anjali Pandey and Richard Crockett further demonstrate his ability to work effectively in teams, fostering innovation and creative problem-solving. As Chen continues to make strides in his field, it is clear that his contributions will have a lasting impact on the world of pharmaceutical research and development.